logo

Breaking News

Share SHARE

Amgen (AMGN) announced positive results from a planned overall survival (OS) interim analysis of the Phase 3 head-to-head ENDEAVOR trial. The study met the key secondary endpoint of OS, demonstrating that patients with relapsed or refractory multiple myeloma treated with KYPROLIS (carfilzomib) and dexamethasone...

Sempra Energy (SRE) increased its 2017 earnings-per-share guidance range to $4.85 to $5.25 from the prior range of $4.80 to $5.20. Analysts polled by Thomson Reuters expected the company to report earnings of $5.11 per share for fiscal year 2017. Analysts' estimates typically exclude special items. Sempra...

Teva Pharmaceutical Industries Ltd. (TEVA) announced the U.S. FDA has accepted the New Drug Application and granted Priority Review for SD-809 (deutetrabenazine) for the treatment of tardive dyskinesia. The FDA has assigned a PDUFA goal date of August 30, 2017. The NDA for SD-809 is based on results...

Domino's Pizza, Inc. (DPZ) reported fourth-quarter EPS of $1.48, up 28.7% over the prior-year quarter as-adjusted EPS of $1.15. On average, 17 analysts polled by Thomson Reuters expected the company to report profit per share of $1.44 for the quarter. Analysts' estimates typically exclude special items....

Libbey Inc. (LBY), glass tableware manufacturers in the world, reported that its net loss in fourth quarter 2016 was $2.2 million or $0.10 per share, compared to net income of $32.1 million or $1.45 per share in fourth quarter 2015. The fourth quarter 2015 included the reversal of substantially all of...

Diebold Nixdorf, Inc. (DBD) on Tuesday reaffirmed its full-year 2017 financial guidance. The company also introduced its multi-year business integration and cost-savings program, named DN2020, and provided key financial targets for 2020. For 2017, the company continues to expect full-year revenue...

NRG Energy Inc. (NRG) reported full year 2016 net loss available for common Stockholders of $701 million, or $2.22 per share, compared to a loss of $6.40 billion or $19.46 per share last year. The loss and resulting loss per share were driven by a $1.2 billion impairment of goodwill and fixed assets...

AT&T Inc. (T) said it expects its 2017 capital expenditure to be in the $22 billion range, which will bring its 2-year total to more than $40 billion. The company noted that more than 40 percent of that 2-year total will help it expand and enhance its portfolio of mobile and integrated business solutions...

Endo International plc (ENDP, ENDP.TO) Tuesday said it expects fiscal 2017 earnings per share from continuing operations to be between $0.04 and $0.34, and adjusted earnings per share from continuing operations to be between $3.45 to $3.75. The company expects 2017 revenues to range from $3.45 billion...

Valeant Pharmaceuticals International, Inc. (VRX, VRX.TO) reported that its net loss attributable to the company for the fourth quarter of 2016 widened to $515 million or $1.47 per share from $385 million or $1.12 per share in the fourth quarter of 2015, hurt by increases in interest expense of $34 million,...

PAREXEL International Corp. (PRXL) announced the appointment of Simon Harford as Senior Vice President and CFO, effective June 1, 2017. He will serve on PAREXEL's Business Review Committee, and assist in developing and implementing strategic objectives. Harford joins the company from GlaxoSmithKline...

While reporting its fourth-quarter financial results today, NRG Yield, Inc. (NYLD, NYLD.A) said that on February 24, it entered into a definitive agreement to acquire the Agua Caliente and Utah utility-scale solar projects from NRG Energy Inc. (NRG) for cash consideration of $130 million, plus assumed...

EMD Serono, the biopharmaceutical business of Merck KGaA in the US and Canada, and Pfizer Inc. announced that the US FDA has accepted for Priority Review EMD Serono's Biologics License Application (BLA) for avelumab as a treatment for patients with locally advanced or metastatic urothelial carcinoma...

Avnet (AVT) announced that its Board approved an expansion of the company's current share repurchase authorization by $500 million. Avnet now has $675 million available for share repurchases when combined with prior authorizations, and the latest authorization has no expiration date. In addition,...

Bank of Montreal (BMO,BMO.TO) said that it plans to purchase, for cancellation, up to 15 million of its common shares under a normal course issuer bid through the facilities of the TSX. The normal course issuer bid, subject to regulatory approvals, will commence on or around May 1, 2017, and will...

Follow RTT